CIK: 1725663 - Address: C/O Entrada Therapeutics, Inc., One Design Center Place, Suite 17-500, Boston, MA 02210
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/13/24 16:47
11/11/24
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.d-17319.980-9-1074D
9/10/24 16:34
9/9/24
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS-4814.970-3-476D
7/10/24 16:34
7/8/24
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS-2614.950-2-281D
3/8/24 16:36
3/6/24
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS-5012.310-4-574D
12/26/23 16:35
12/21/23
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.dm-19515.590-13-2050D
9/6/23 17:11
9/6/23
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.d-1313.480-1-250D
7/12/23 16:34
7/10/23
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.dm-18017.990-10-2137D
6/23/23 16:20
6/21/23
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.d-26315.010-18-3828D
3/3/23 16:37
3/2/23
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.d-1810.530-2-442D
12/12/22 16:36
12/8/22
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.d-8618.950-5-2217D
12/6/22 17:02
12/2/22
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.dm-5718.190-3-1617D
11/18/22 16:59
11/16/22
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.d-418.1000-117D
8/26/22 16:06
8/24/22
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.dm-6413.780-5-3011D
8/23/22 18:28
8/19/22
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.dm-15213.080-12-4415D
8/18/22 18:53
8/16/22
TRDAEntrada Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWentworth Kory JamesMAOCFOS.dm-813.020-1-320D
8/5/20 16:06
8/3/20
BLUEBluebird Bio, Inc.DEHealthBioPrdBiological Products, (No DiagWentworth Kory JamesMAOPrincipaS-561.0000-110D
7/22/20 17:22
7/20/20
BLUEBluebird Bio, Inc.DEHealthBioPrdBiological Products, (No DiagWentworth Kory JamesMAOPrincipaS-4066.380-1-610D
6/8/20 16:24
6/4/20
BLUEBluebird Bio, Inc.DEHealthBioPrdBiological Products, (No DiagWentworth Kory JamesMAOPrincipaS-1065.2300-110D
1/9/20 17:33
1/7/20
BLUEBluebird Bio, Inc.DEHealthBioPrdBiological Products, (No DiagWentworth Kory JamesMAOPrincipaS-2089.9700-36D
12/23/19 17:00
12/19/19
BLUEBluebird Bio, Inc.DEHealthBioPrdBiological Products, (No DiagWentworth Kory JamesMAOPrincipaS-3792.5900-66D
6/7/19 16:11
6/5/19
BLUEBluebird Bio, Inc.DEHealthBioPrdBiological Products, (No DiagWentworth Kory JamesMAOPrincipaS-8127.6000-17D
3/4/19 16:34
2/28/19
BLUEBluebird Bio, Inc.DEHealthBioPrdBiological Products, (No DiagWentworth Kory JamesMAOPrincipaS-8151.7100-17D
2/27/19 16:57
2/25/19
BLUEBluebird Bio, Inc.DEHealthBioPrdBiological Products, (No DiagWentworth Kory JamesMAOPrincipaS-31150.0000-37D
1/30/19 16:35
1/28/19
BLUEBluebird Bio, Inc.DEHealthBioPrdBiological Products, (No DiagWentworth Kory JamesMAOPrincipaS-26125.9600-54D
12/21/18 16:26
12/19/18
BLUEBluebird Bio, Inc.DEHealthBioPrdBiological Products, (No DiagWentworth Kory JamesMAOPrincipaS-40103.0500-85D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact